Publicacions (19) Publicacions de SHEILA GONZÁLEZ SALVATIERRA

2024

  1. Mild hypophosphatasia may be twice as prevalent as previously estimated: an effective clinical algorithm to detect undiagnosed cases

    Clinical Chemistry and Laboratory Medicine, Vol. 62, Núm. 1, pp. 128-137

2023

  1. Analysis of the Genetic Relationship between Atherosclerosis and Non-Alcoholic Fatty Liver Disease through Biological Interaction Networks

    International Journal of Molecular Sciences, Vol. 24, Núm. 4

  2. Cardioprotective function of sclerostin by reducing calcium deposition, proliferation, and apoptosis in human vascular smooth muscle cells

    Cardiovascular Diabetology, Vol. 22, Núm. 1

  3. Do patients with type 2 diabetes have impaired hip bone microstructure? A study using 3D modeling of hip dual-energy X-ray absorptiometry

    Frontiers in Endocrinology, Vol. 13

  4. Systemic effects of hypophosphatasia characterization of two novel variants in the ALPL gene

    Frontiers in Endocrinology, Vol. 14

2022

  1. Characterization of Genetic Variants of Uncertain Significance for the ALPL Gene in Patients With Adult Hypophosphatasia

    Frontiers in Endocrinology, Vol. 13

  2. Exploring the Role of Sclerostin as a Biomarker of Cardiovascular Disease and Mortality: A Scoping Review

    International Journal of Environmental Research and Public Health, Vol. 19, Núm. 23

  3. Genetic relationship between pulmonary diseases of environmental or occupational origin and osteoporosis: a bioinformatic approach

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 13, Núm. 4, pp. 130-136

  4. Identification of Potential Targets Linked to the Cardiovascular/Alzheimer’s Axis through Bioinformatics Approaches

    Biomedicines, Vol. 10, Núm. 2

  5. The Contribution of Wnt Signaling to Vascular Complications in Type 2 Diabetes Mellitus

    International Journal of Molecular Sciences, Vol. 23, Núm. 13

  6. Undercarboxylated Osteocalcin: A Promising Target for Early Diagnosis of Cardiovascular and Glycemic Disorders in Patients with Metabolic Syndrome: A Pilot Study

    Nutrients, Vol. 14, Núm. 14

2021

  1. 3d dxa hip differences in patients with acromegaly or adult growth hormone deficiency

    Journal of Clinical Medicine, Vol. 10, Núm. 4, pp. 1-12

  2. Genetic relationship between pulmonary diseases of environmental or occupational origin and osteoporosis: a bioinformatic approach

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 13, Núm. 4, pp. 130-136

  3. Hypophosphatasia: A unique disorder of bone mineralization

    International Journal of Molecular Sciences, Vol. 22, Núm. 9

  4. Lower trabecular bone score in type 2 diabetes mellitus: A role for fat mass and insulin resistance beyond hyperglycaemia

    Diabetes and Metabolism, Vol. 47, Núm. 6

  5. Osteoglycin as a potential biomarker of mild kidney function impairment in type 2 diabetes patients

    Journal of Clinical Medicine, Vol. 10, Núm. 10

2020

  1. Association between oxidative-stress-related markers and calcified femoral artery in type 2 diabetes patients

    Journal of Pharmaceutical and Biomedical Analysis, Vol. 190

  2. Circulating Undercarboxylated Osteocalcin as Estimator of Cardiovascular and Type 2 Diabetes Risk in Metabolic Syndrome Patients

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Epidemiological, Clinical and Genetic Study of Hypophosphatasia in A Spanish Population: Identification of Two Novel Mutations in The Alpl Gene

    Scientific Reports, Vol. 9, Núm. 1